ImmuDyne Announces New CFO to Take Company through Next Phase of Growth
October 04 2017 - 10:53AM
ImmuDyne, Inc. (OTCQB:IMMD) (“ImmuDyne” or the “Company”), a leader
in the development and online marketing of OTC health and wellness
products addressing large unmet needs, today announced Robert
Kalkstein will be joining the company as Chief Financial Officer.
As CFO of ImmuDyne, Robert will be responsible for ensuring the
finance organization can support ImmuDyne’s aggressive growth plans
both at present and in the future.
"Robert brings a strong background to our finance team from his
experience in audit, banking and as CFO at several emerging growth
companies where he successfully provided the financial strategy and
leadership to help the organizations get to the next level of
growth," said Mark McLaughlin, president and CEO, ImmuDyne. "With
Robert, I'm confident we'll be well positioned to meet our goals of
consistent profitable growth moving forward. We're excited to have
him on the ImmuDyne team."
Previously Robert held positions at Peerless System Corp.,
Jefferies & Co. and PricewaterhouseCoopers. He has more
than 10 years of experience in the areas of accounting, finance,
SEC compliance and operations. Mr. Kalkstein is a CPA and received
a Bachelor of Engineering in Biomedical Engineering and a Masters
of Engineering in Engineering Management at Stevens Institute of
Technology in Hoboken, NJ.
“I am both honored and excited to be a part of ImmuDyne at this
time,” said Robert Kalkstein. “I am impressed with ImmuDyne’s
growth over the past 24 months and believe there is a big
opportunity ahead. I look forward to contributing to the success of
the Company.”
About lmmuDyne
ImmuDyne, Inc. (the "Company") is a health and wellness company
that develops, manufactures, and markets innovative consumer
products. ImmuDyne manufactures and markets a proprietary and
patent protected Yeast Beta Glucan that has been shown in thousands
of clinical studies to support and regulate the human immune
system. It has broad applications in skincare and as an
immune support supplement. ImmuDyne PR, a majority owned
subsidiary of ImmuDyne, Inc., is the digital marketing arm of
ImmuDyne and is currently focused on marketing products for thicker
and fuller hair (Shapiro MD) and a skincare line containing
ImmuDyne’s proprietary Yeast Beta Glucan ingredient (Inate
MD). All of lmmuDyne's intellectual property is protected by
patents and/or trade secrets. Additional information can be found
on the web at www.immudyne.com
Forward-Looking Statements Cautionary language regarding
Forward-Looking Statements Safe Harbor Act Disclaimer: Forward
looking statements in this release are made pursuant to the Safe
Harbor Provisions of the Private Securities Litigation Reform Act
of 1995. Certain statements in this press release, including
projections with respect to lmmuDyne's results of operations, may
contain words such as "anticipates," "believes," "could,"
"estimates," "expects," "intends," "may," "projects,"
"plans," "targets" and other similar language and are
considered forward-looking statements. These statements are based
on management's current expectations, estimates, and forecasts.
These forward-looking statements are subject to important
assumptions, risks and uncertainties, which are difficult to
predict and therefore the actual results may be materially
different from those discussed.
The preliminary, unaudited information provided above is based
on the Company’s current estimate of results from operations for
the second quarter and its cash at June 30, 2017, and remains
subject to change based on the Company’s closing procedures,
including the subsequent occurrence or identification of events
prior to the formal issuance of the quarterly financial
statements.
Investor Relations Contact:
ImmuDyne, Inc.
Bernard Girma +1-949-215-7754